This basic but wide-ranging course covers techniques for investigating, visualising and performing basic statistical techniques on data sets typical to industry settings. There are many basic concepts that need to be understood before statistics can be used to its full potential to give useful and informative answers. This course ensures that these concepts are understood in a non-technical way and then demonstrated using data examples.
Mathematical details are kept to a necessary minimum and we focus on the interpretation of statistical output and illustrate applications with data from dummy clinical trials or published data. The objective of the course is not to teach you how to become a statistician, but to help you work with statisticians and get the maximum value from statistical output.
The course will consist of lectures, practical examples and discussions. There will not be any computer exercises.
This is a 1-day course, aimed to introduce statistics to people who work on Clinical Trials, but who are not Statisticians. No previous knowledge of Statistics is assumed as we start right at the beginning with the basics. Many practical examples are given and the emphasis is on application and understanding rather than the equations and the technical background.
The basics of statistics are discussed to give background and a common base to start from and the applications and use of statistics in drug development is then discussed. The role of the statistician and their ability to help with decision making is also discussed.
It also serves as a useful refresher course to those who once studied statistics as part of a college course.
Gemma Hodgson has worked in the Pharmaceutical industry for over 20 years. After receiving her first degree from Imperial College (Maths with Statistics) and then an MSc in Medical Statistics from London School of Tropical Hygiene and Medicine, Gemma began her career at Pfizer in Sandwich working in experienced global teams on major phase 3 projects. After 13 years at Pfizer and working in all phases of development, from phase 1 to phase 4, Gemma then moved to Takeda R &D in London where she worked on later phase projects, focussing on close liaison with other departments within the organisation. In 2012 Gemma left Takeda to work for a statistical training and consultancy firm, Qi Statistics Ltd, where training of non-statisticians and explaining statistical concepts to non-scientific audiences is key. Gemma has a broad interest in the application of statistics and is an experienced trainer to all types of audience, specialising in translating technical concepts into everyday English.
Course runs from: 09:30 – 16:30 (registration/coffee from 9:00)
Registration costs (includes lunch and refreshments).
Registration on or before 10th August 2018
Registration after 10th August 2018
£425 + VAT
£495 + VAT
Registration has now closed.
PSI aims to be fully inclusive and endeavours to accommodate delegates with disabilities wherever possible. Please help us to help you by letting us know if you require additional facilities or have any special requirements. Please contact us on +44 (0)1730715235 or at email@example.com for further information.
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.